BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4019749)

  • 1. Antibody response of rabbits to nerve ending gangliosides. Analysis of antibody specificity by liposome lysis and lysis inhibition assays.
    Uemura K; Kitazawa N; Taketomi T
    J Neuroimmunol; 1985 Sep; 9(5):269-80. PubMed ID: 4019749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-dependent immune damage to liposomes containing gangliosides.
    Shichijo S; Toffano G; Alving CR
    J Immunol Methods; 1985 Dec; 85(1):53-63. PubMed ID: 4078313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to ganglio-series gangliosides in different strains of inbred mice.
    Kawashima I; Nakamura O; Tai T
    Mol Immunol; 1992 May; 29(5):625-32. PubMed ID: 1584231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
    Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
    Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of gangliosides on immune reactions of antibodies to neutral glycolipids in liposomes.
    Shichijo S; Alving CR
    Biochim Biophys Acta; 1986 Jun; 858(1):118-24. PubMed ID: 3707956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological specificity of the liposome lysis test for measurement of anti-ganglioside antibodies. A comparison with hemagglutination inhibition.
    Zemmour J; Portoukalian J; Doré JF
    J Immunol Methods; 1984 Feb; 66(2):331-40. PubMed ID: 6361155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
    Yuki N; Yoshino H; Sato S; Ohno T; Miyatake T
    Rinsho Shinkeigaku; 1990 Sep; 30(9):989-93. PubMed ID: 2265511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.
    Livingston PO; Ritter G; Calves MJ
    Cancer Immunol Immunother; 1989; 29(3):179-84. PubMed ID: 2731184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of melanoma-associated gangliosides in cancer patients.
    Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
    Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.
    Kotani M; Ozawa H; Kawashima I; Ando S; Tai T
    Biochim Biophys Acta; 1992 Jul; 1117(1):97-103. PubMed ID: 1627599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
    Nobile-Orazio E; Giannotta C; Briani C
    J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical determination of ganglioside GM2, by inhibition of complement-dependent liposome lysis.
    Geiger B; Smolarsky M
    J Immunol Methods; 1977; 17(1-2):7-19. PubMed ID: 333030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of ganglioside binding to rat macrophages.
    Förster O; Boltz-Nitulescu G; Holzinger C; Wiltschke C; Riedl M; Ortel B; Fellinger A; Bernheimer H
    Mol Immunol; 1986 Nov; 23(11):1267-73. PubMed ID: 3821740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential reactivities of fucosyl GM1 and GM1 gangliosides on rat erythrocyte membrane revealed by analysis with anti-fucosyl GM1 and GM1 antisera.
    Iwamori M; Shimomura J; Tsuyuhara S; Mogi M; Ishizaki S; Nagai Y
    J Biochem; 1983 Jul; 94(1):1-10. PubMed ID: 6619101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
    Livingston PO; Ritter G; Srivastava P; Padavan M; Calves MJ; Oettgen HF; Old LJ
    Cancer Res; 1989 Dec; 49(24 Pt 1):7045-50. PubMed ID: 2582446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
    Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
    Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).
    Young WW; MacDonald EM; Nowinski RC; Hakomori SI
    J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of apparent neurological abnormalities in rabbits sensitized by gangliosides.
    Dasgupta S; Li D; Yu RK
    Neurochem Res; 2004 Nov; 29(11):2147-52. PubMed ID: 15662849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.